Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2006 | 12-2005 | 06-2005 | 12-2004 | 06-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,310 | -1,810 | -2,180 | -1,030 | -3,070 |
| Depreciation Amortization | 40 | 20 | 40 | 20 | 30 |
| Other Working Capital | 60 | 90 | -10 | 30 | 160 |
| Other Operating Activity | 680 | 570 | 40 | 190 | 990 |
| Operating Cash Flow | $-2,530 | $-1,130 | $-2,110 | $-790 | $-1,890 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | -6 | -2 | -4 |
| Other Investing Activity | 2,540 | 920 | -764 | 1,202 | -2,196 |
| Investing Cash Flow | $2,540 | $920 | $-770 | $1,200 | $-2,200 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 10 | 0 | 2,990 | 40 | 3,960 |
| Financing Cash Flow | $10 | $0 | $2,990 | $40 | $3,960 |
| Beginning Cash Position | 290 | 290 | 180 | 180 | 320 |
| End Cash Position | 310 | 80 | 290 | 630 | 180 |
| Net Cash Flow | $20 | $-210 | $100 | $450 | $-130 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,530 | -1,130 | -2,110 | -790 | -1,890 |
| Free Cash Flow | -2,530 | -1,130 | -2,110 | -790 | -1,890 |